⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 6, 2024Open Access

Table S2 from Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma

George A. Ward Zhiqiang Zhang Simone Jueliger Ilya S. Potapov Matthew P. Davis Adam R. Boxall Jason Taylor Harold Keer Andrea Biondo John F. Lyons Martin Sims Tomoko Smyth

View Full Paper

Ask AI

Bookmark

Share

Abstract

Table S2. Details of TaqMan primers used in qPCR assays in this study (Figures 2,5 & S9).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ward et al. (2024) studied this question.

synapsesocial.com/papers/68e65e2bb6db6435875ec810 https://doi.org/10.1158/2767-9764.25983606.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S2 from Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma2024
2Table S1 from Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma2024
3Table S1 from Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma2024
4Figure S5 from Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma2024
5Figure S7 from Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma2024